Abstract
Keywords
Stachys lavandulifolia Vahl. Rat Ileum Antispasmodic Extract
Introduction
Diarrhea continues to be one of the leading causes of mortality and morbidity especially in children in developing countries (1). Diarrhea is characterized by hypermotility of gastrointestinal tract (2). Natural products have served as a medicinal source for centuries, and about half of the pharmaceuticals in use today are derived from natural products (3). Stachys lavandulifolia Vahl. from Lamiaceae is used in Iranian traditional medicine as an anxiolytic and to treat diarrhea (4). Furthermore, experimental studies have demonstrated the anxiolytic effect of S. lavandulifolia in mice (5, 6). Despite the extraction of S. lavandulifolia constituents such as α-pinene, myrcene, β-phellandrene and β-caryophyllene (4), its pharmacological effects on isolated smooth muscle have not been evaluated scientifically yet. Therefore, the aim of the present study was to investigate the antispasmodic potential of the S. lavandulifolia crude extract and its fractions on rat ileum.
Experimental
Plant material
Stachys lavandulifolia Vahl. was collected (March 2008) from Zanjan province (center of Iran) and authenticated by Dr. Namjoyan from the Pharmacognosy Department of the Ahwaz Jundishapur University of Medical Sciences (AJUMS). A voucher specimen was deposited in the herbarium of the School of Pharmacy of AJUMS.
Extraction and fractionation
The aerial parts of the herb were dried in shade. The powder of the herb was macerated with methanol (90%) for 72 h at room temperature to obtain the crude extract (CE). The mixture was filtered (Whatman No.1) and the filtrate was concentrated by rotary evaporator and was air-dried in the next step (yield: 17.22%). Petroleum ether fraction (PF) was prepared from the CE (16.8 g) being mixed with 70 mL distilled water and 70 mL petroleum ether. The extraction was reported for three times followed by concentrating and air-drying (yield: 14.27%). In order to obtain the chloroformic fraction (CF), the PF was mixed with chloroform (70 mL) and then the mixture was concentrated and air-dried (yield: 1.74%). The same procedure was repeated in order to obtain ethyl acetate fraction (EF) using ethyl acetate (70 mL). The extraction process was reported for three times and the mixture was concentrated and thereafter dried (yield: 5.23%). The remaining aqueous fraction (AF) was air-dried (yield: 77%). The extract and fractions were stored at 4ºC until being used.
Animals
Male Wistar rats (190 ± 10 g) were purchased from Animal Facility of AJUMS, housed at 20-24°C with 12 h/12 h light/dark cycle and free access to food and water. All animals used in this study were treated in accordance with principals and guidelines on Ethics Committee of AJUMS. The rats were deprived of food (not water) for 24 h before the experiment.
Ileum preparation
On the day of experiment, rats were sacrificed by a sharp blow on the head and one or two pieces (1.5-2 cm) of ileum were dissected out from 2 cm above the ileocaecal junction and mounted between two stainless steel hooks in tissue bath (10 mL) containing Tyrode solution (37°C and pH of 7.4). The lower hook was fixed at the bottom of the tissue bath and the upper one was connected to an isotonic transducer (Harvard Transducer, UK). Each tissue was placed under 1 g resting tension and equilibrated for 60 min prior to the execution of experimental protocols. During this period, the tissue was washed with Tyrode solution every 15 min and the tension was readjusted to 1 g. Ileum contractions were displayed and recorded on Universal Harvard Oscillograph, (UK). Tyrode solution composition consisted of (in mM) NaCl (136.9), KCl (2.6), CaCl2 (1.8), NaHCO3 (11.9), NaH2PO4 (0.42), MgCl2 (1.05) and glucose (5.55) which continuously was bubbled with air. The ileum contractions were induced by KCl (60 mM) or carbachol (CCh, 10 μM) and once the plateau was achieved, the crude extracts or fractions were added cumulatively (0.125-4 mg/mL of CE and 0.05-0.8 mg/mL of the fractions) to the tissue bath. The mechanism of CF spasmolytic activity was studied by separate tissue incubations either with propranolol (1 µM, 30 min), naloxone (1 µM, 30 min) or NG -nitro - L - arginine methyl ester (L-NAME, 100 µM, 20 min) as non-selective β-adrenoceptors, opioid receptors antagonists and nitric oxide synthase inhibitor, respectively. The calcium influx involvement was further evaluated by depolarizing the ileum in Ca2+-free Tyrode solution with high K+ (60 mM) and then applying CaCl2 (0.2-0.6 mM) cumulatively to induce contraction. Same protocol was repeated after incubating the ileum with CF (0.01-0.04 mg/mL) for 5 min. To solve the fractions, DMSO (50 µL) was used and then Tyrode solution was added to make the final solution.
Chemicals
CCh, propranolol and L-NAME were purchased from Sigma (Sigma, USA), naloxone was purchased from Tolidaru Company (Tolidaru, Iran) and DMSO was purchased from Merck (Merck, Germany).
Data analysis
Plateau of ileum KCl- or CCh-induced contraction was assumed as 100% and the relaxations evoked by extract or fractions, were calculated (as %) and the results were expressed as mean ± SEM for n number of animals. Multiple means were compared by one-way and two-way analysis of variance (ANOVA) followed by Dunnett>s test. A p- value of less than 0.05 was considered a significant difference. Statistical analysis was performed using SPSS (version 16.0).
Results
Antispasmodic activity of the CE
Cumulative concentrations of CE (0.125-4 mg/mL) attenuated (p < 0.001) the KCl-induced ileum contraction (IC50 = 0.719 ± 0.044 mg/mL) in a concentration-dependent manner (Figure 1).
Antispasmodic activity of fractions
KCl-induced ileum contractions were attenuated with cumulative concentrations (0.05-0.8 mg/mL) of all fractions. PF, CF and EF (but not AF), elucidated antispasmodic activity in a concentration-dependent manner (p < 0.001). The IC50 of EF (n = 10), PF (n = 7) and CF (n = 8) were 0.758 ± 0.099, 0.393 ± 0.154 and 0.126 ± 0.018 mg/mL, respectively. PF and EF activities were not significantly different (Figure 2). CF (with lowest IC50) was chosen for further studies.
Effects of L-NAME, propranolol and naloxone on CF antispasmodic activity
In the ileum precontracted by KCl, the CF (0.05-0.8 mg/mL) spasmolytic effect was unaffected by tissue incubation with L-NAME (20 min, 100 µM, n = 7) or propranolol (30 min, 1 µM, n = 7). However, naloxone (30 min, 1 µM, n = 9) reduced the spasmolytic activity of chloroformic fraction (two-way ANOVA, p < 0.01) (Figure 3).
Effect of CF on CaCl2-induced ileum contraction
In Ca2+-free with high K+ (60 mM) Tyrode solution, cumulative concentrations of CaCl2 (0.2-0.6 mM) induced ileum contractions in a concentration-dependent manner (one-way ANOVA, p < 0.001). Five min ileum incubation with CF (0.01-0.04 mg/mL) attenuated the CaCl2-induced contractions. The CaCl2-induced ileum contractions in the absence and in the presence of lowest concentration of CF (0.01 mg/mL) were significantly different (two-way ANOVA, p < 0.001) (Figure 4).
Effect of CF on CCh-induced ileum contraction
The chloroformic fraction (0.05-0.8 mg/mL) attenuated the CCh (10 µM)-induced ileum contraction in a concentration-dependent fashion (one-way ANOVA, p < 0.001) and IC50 was 0.184 ± 0.014 mg/mL. The CF antispasmodicactivities on contractions induced by KCl and CCh have been compared in Figure 5.
Effect of DMSO on KCl and CCh-induced ileum contractions
Since DMSO was used to solve S. lavandulifolia fractions, the possible role of DMSO in the CF antispasmodic activity was studied by applying this solvent to the ileum contractions induced by KCl (60 mM) or CCh (10 µM). Results showed that ileum contractions were unaffected by DMSO (0.005-0.08 w/w).
Discussion
The most distinctive finding of the present study was the antispasmodic effect of S. lavandulifolia on rat ileum. The observed spasmolytic effect was not reversible completely since the ileum responsiveness to spasmogens was not reestablished after refreshing the tissue bath solution. The comparison of spasmolytic effect of crude extract and fractions indicated that chloroformic fraction (CF) with lowest IC50 was the most potent fraction.
The contraction in the smooth muscle is dependent on presence of sufficient cytosolic Ca2+ which can be provided by two main sources: 1) by extracellular fluid mainly via voltage-dependent calcium channels; 2) by releasing Ca2+ from intracellular calcium pools such as sarcoplasmic reticulum (7). In the KCl-induced smooth muscle contraction, the voltage-dependent calcium channels (VDCCs) are involved (8) and the existence of L-type VDCCs in rat ileum has been reported (9). On the other hand, CCh (muscarinic receptor agonist) induces ileum contraction via M2 and M3 receptors (10). Binding CCh to these receptors increases intracellular calcium concentration (11) by both Ca2+ influx through L-type Ca2+ channels and releasing calcium from cytoplasmic calcium stores (8). The ileum contractions induced by KCl and CCh were not significantly different. CF at 0.2 mg/mL, however, abolished (115%) the KCl-induced contraction but relatively inhibited (66%) the CCh-induced contraction. Thus, the KCl-induced contraction was more susceptible to CF than the one elicited by CCh, which suggested that events at the cholinergic receptors level were not important.
It has been suggested that the substance that inhibits the KCl-induced smooth muscle contraction is considered as a Ca2+ influx blocker (12). The result of CF spasmolytic effect on CaCl2-induced contractions supports this suggestion, since high K+ in the Ca2+-free Tyrode solution depolarizes the ileum (13) and the contraction may occur only after applying CaCl2 (11). Furthermore, KCl and CCh increase intracellularCa2+ by activating the calcium channels which suggests that CF of S. lavandulifolia has inhibited Ca2+ mobilization.
Activation of β-adrenoceptor activation evokes the ileum relaxation (14). The ineffectiveness of propranolol in attenuating the CF spasmolytic effect, however, indicates that β-adrenoceptors were not involved in CF activity.
Nitric oxide as a main inhibitory neurotransmitter in the gut (15) modulates the contractility of small intestine through cGMP (16) but, the ineffectiveness of L-NAME (nitric oxide synthase inhibitor) to attenuate the CF spasmolytic effect indicates that CF activity was not mediated through nitric oxide. Opioid receptors activation relaxes the ileum smooth muscle (17) and in our study, naloxone (non-selective opioid receptors antagonist) partially but significantly reduced the CF effect which suggests that CF activity has been mediated, at least partially, via these receptors. Furthermore, the KCl- and CCh-induced ileum contractions were unaffected by DMSO indicating that the observed CF spasmolytic activity was not due to DMSO effect.
The main constituents of S. lavandulifoliaare alpha-pinene, myrcene, β-phellandrene and β-caryophyllene (4) whichsome of them have spasmolytic effect (18, 19). The existence of apigenin and luteolin in S. lavandulifolia (20) and the antispasmodic effects of these two flavonoids have been demonstrated (21-23), therefore, it seems that the observed spasmolytic effect of S. lavandulifolia was due to its flavonoid constituents. Relatively low IC50 of the chloroformic fraction of S. lavandulifoliasuggests possible beneficial effects of this herb on which, however, further research is needed to be confirmed.
In conclusion, S. lavandulifolia Vahl. chloroformic fraction of aerial parts, particularly, induced spasmolytic effect in the isolated rat ileum mainly by disturbing calcium influx and partly via opioid receptors activation. The obtained results support the traditional usage of this herb to treat diarrhea.
Acknowledgements
References
-
1.
Thapar N, Sanderson IR. Diarrhea in children: an interface between developing and developed countries. Lancet. 2004;363:641-653. [PubMed ID: 14987892].
-
2.
Fine KD, Schiller LR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology. 1999;116:1464-1486. [PubMed ID: 10348832].
-
3.
Clark AM. Natural products as a source for new drugs. Pharm. Res. 1996;13:1133-1144. [PubMed ID: 8865302].
-
4.
Meshkatalsadat MH, Sajjadi E, Amiri H. Chemical constituents of the essential oils of different stages of the growth of Stachys lavandulifolia Vahl. from Iran. Pak. J. Biol. Sci. 2007;10:2784-2786.
-
5.
Rabbani M, Sajjadi SE, Zarei HR. Anxiolytic effects of Stachys lavandulifolia Vahl. on the elevated plus-maze model of anxiety in mice. J. Ethnopharmacol. 2003;89:271-276. [PubMed ID: 14611891].
-
6.
Rabbani M, Sajjadi SE, Jalali A. Hydroalcoholic extract and fractions of Stachys lavandulifolia Vahl.: effects on spontaneous motor activity and elevated plus-maze behaviour. Phytother. Res. 2005;19:854-858. [PubMed ID: 16261514].
-
7.
Borrelli F, Cappasso F, Cappaso R, Ascione V, Aviello G, Longo R, Izzo AA. Effect of Boswellia serrata on intestinal motility in rodent: Inhibition of diarrhea without constipation. Br. J. Pharmacol. 2006;148:553-560. [PubMed ID: 16633355].
-
8.
Tanovic A, Jimenez M, Fernandez E. Lack of effect of nitric oxide on KCl, acetylcholine and substance P induced contraction in ileum longitudinal muscle of the rat. Life Sci. 2000;67:531-541. [PubMed ID: 10993118].
-
9.
El Bardai S, Hamaide MC, Lyoussi B, Quetin-Leclercq J, Morel N, Wibo M. Marrubenol interacts with the phenylalkylamine binding site of the L-type calcium channel. Eur. J. Pharmacol. 2004;492:269-272. [PubMed ID: 15178374].
-
10.
Coulson FR, Jacoby DB, Fryer AD. Insulin regulates neuronal M2 muscarinic receptor function in the ileum of diabetic rats. J. Pharmacol. Exp. Ther. 2004;308:760-766. [PubMed ID: 14610235].
-
11.
Zhang WW, Li Y, Wang XQ, Tian F, Cao H, Wang MW, Sun QS. Effects of magnolol and honokiol derived from traditional Chinese herbal remedies on gastrointestinal movement. World J. Gastroenterol. 2005;11:4414-4418. [PubMed ID: 16038044].
-
12.
Gilani AH, Bashir S, Janbaz KH, Shah AJ. Presence of cholinergic and calcium blocking activities explains the traditional use of Hibiscus rosasinensis in constipation and diarrhea. J. Ethnopharmacol. 2005;102:289-294. [PubMed ID: 16182481].
-
13.
Fujimoto S, Mori M. Characterization of capsaicin-induced, capsazepine-insensitive relaxation of ileum smooth muscle of rats. Eur. J. Pharmacol. 2004;487:175-182. [PubMed ID: 15033390].
-
14.
Brown KJ, Summers RJ. β1 and β3-adreneoceptor mediated smooth muscle relaxation in hypothyroid rat ileum. Eur. J. Pharmacol. 2001;415:257-263. [PubMed ID: 11275008].
-
15.
Izzo AA, Mascolo N, Capasso F. Nitric oxide as a modulator of intestinal water and electrolyte transport. Dig. Dis. Sci. 1998;43:1605-1620. [PubMed ID: 9724140].
-
16.
Grasa L, Rebollar E, Arruebo MP, Plaza MA, Murillo MD. The role of NO in the contractility of rabbit small intestine in-vitro: effect of K+ channels. J. Physiol. Pharmacol. 2005;56:407-419. [PubMed ID: 16204763].
-
17.
Gray AC, White PJ, Coupar IM. Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum. Br. J. Pharmacol. 2005;144:687-694. [PubMed ID: 15678085].
-
18.
Mata R, Rojas A, Acevedo L, Estrada S, Calzada F, Rojas I, Bye R, Linares E. Smooth muscle relaxing flavonoids and terpenoids from Conyza filaginoides. Planta Med. 1997;63:31-35. [PubMed ID: 9063094].
-
19.
Camara CC, Nascimento NR, Macedo-Filho CL, Almedia FBS, Fonteles MC. Antispasmodic effect of the essential oil of Plectranthus barbatus and some major constituents on the guinea-pig ileum. Planta Med. 2003;69:1080-1085. [PubMed ID: 14750021].
-
20.
Safaei A. Identification and quantitative determination of luteolin and apigenin in the aerial parts and an extract of Stachys lavandulifolia by HPLC. Iranian J. Pharm. Res. 2004;2(Suppl. 90):274.
-
21.
Weimann C, Goransson U, Pongprayoon-Claeson Y, Claeson P, Bohlin L, Rimpler H, Heinrich M. Spasmolytic effects of Baccharis conferta and some of its constituents. J. Pharm. Pharmacol. 2002;54:99-104. [PubMed ID: 11829135].
-
22.
Lemmens-Gruber R, Marchart E, Rawnduzi P, Engel N, Benedek B, Kopp B. Investigation of the spasmolytic activity of the flavonoids fraction of Achilla millefolium s.l. on isolated guinea-pig ilea. Arzneimittelforchung. 2006;56:582-588. [PubMed ID: 17009839].
-
23.
Gharzouli K, Holzer P. Inhibition of guinea pig intestinal peristalsis by the flavonoids quercetin, naringenin, apigenin and genistein. Pharmacology. 2004;70:5-14. [PubMed ID: 14646351].